Blood test may solve diagnostic puzzle for rare inflammatory diseases
NCT ID NCT02143986
First seen Nov 01, 2025 · Last updated May 14, 2026 · Updated 24 times
Summary
This study is looking at a specific blood marker called glycosylated ferritin to see if it can help doctors better distinguish between three serious conditions: Still's disease, sepsis, and macrophage activation syndrome. These illnesses can look very similar, making diagnosis difficult. The researchers will measure the percentage of glycosylated ferritin in the blood of 60 people suspected of having one of these conditions to see if the pattern differs between them.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SEPSIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Brugmann University Hospital
RECRUITINGBrussels, 1020, Belgium
Contact Email: •••••@•••••
Contact Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.